Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago
150 mg
3 x 10
৳18.00

Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.

All price changes →

Save on this medicine

Same active ingredient — pay up to 17% less

These brands contain the same active ingredient (L-Ornithine L-Aspartate). Same strength and form. Confirm the switch with your doctor or pharmacist.

From ৳18.00 (3 x 10)
Available as: 150 mg · 3 x 10 150 mg 150 mg 150 mg

Indications & Uses

Hepalola is indicated for the treatment of Hepatic Encephalopathy, Acute Liver Failure, Hyperammonemia due to Acute and Chronic Hepatitis, Fatty Liver, Alcoholic Liver damage, Adjunct to hepatotoxic drugs, Liver Cirrhosis, Post hepatitis convalescence etc.

Dosage Reference

Reference Information Only

Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.

Adults:

Sachet: 1-2 sachets granules is dissolved in a large amount of fluid (e.g. in a glass of water or juice) and is taken orally 3 times a day during or after meals.Injection (Infusion Concentrate): The recommended dose is up to 20 gm (4 ampoules daily). In case of loss of consciousness (pre-coma) and clouding of consciousness (coma) up to 8 ampoules within 24 hours, depending on the severity of the condition.Administrations- L-Ornithine L-Aspartate infusion concentrate can be added to any of the conventional intravenous fluids (0.9% Sodium Chloride, 5% Dextrose and Ringer's lactate etc.) The normal dilution rate is 1 ampoule per 100 ml of I.V. fluid. However, the dose should not exceed 6 ampoules per 500 ml infusion. The solution mixtures were stable up to 24 hours. Infusion Rate: 5 gm/h at maximum.

Side Effects

Very rarely side effects like nausea and vomiting occur. These side effects are usually transient and do not necessitate the withdrawal of the drug.

Cautions & Contraindications

Warnings & Precautions

Monitoring of serum and urinary urea levels at regular intervals should be done.

Last updated: 18 Aug 2026